Detalhe da pesquisa
1.
DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS.
Blood
; 140(11): 1278-1290, 2022 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35639959
2.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
Blood
; 140(11): 1229-1253, 2022 09 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35653592
3.
MYC overexpression in natural killer cell lymphoma: prognostic and therapeutic implications.
Haematologica
; 2024 Mar 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38546691
4.
Lenalidomide maintenance following high-dose therapy and autologous haematopoietic stem cell transplantation in chemo-resistant or high-risk non-Hodgkin lymphoma: A phase I/II study.
Br J Haematol
; 202(1): 116-121, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37096954
5.
Final results of a phase II study of CHOEP plus lenalidomide as initial therapy for patients with stage II-IV peripheral T-cell lymphoma.
Br J Haematol
; 202(3): 525-529, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37217196
6.
Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results.
Blood
; 138(6): 427-438, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33827139
7.
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Blood
; 138(3): 213-220, 2021 07 22.
Artigo
Inglês
| MEDLINE | ID: mdl-34292324
8.
Hematological Oncology journal women in lymphoma special issue: Latest updates in nodal peripheral T-cell lymphoma.
Hematol Oncol
; 2023 Jun 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37309261
9.
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023.
J Natl Compr Canc Netw
; 21(11): 1118-1131, 2023 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37935098
10.
Current Treatments in Mantle Cell Lymphoma.
Oncology (Williston Park)
; 37(8): 326-333, 2023 08 08.
Artigo
Inglês
| MEDLINE | ID: mdl-37616519
11.
Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma.
Haematologica
; 107(3): 690-701, 2022 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33792219
12.
Phase 1 trial of carfilzomib in relapsed/refractory peripheral T-cell lymphoma.
Ann Hematol
; 101(2): 335-340, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34668982
13.
Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?
Future Oncol
; 18(3): 311-321, 2022 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-34761681
14.
A Novel Triple-Action Inhibitor Targeting B-Cell Receptor Signaling and BRD4 Demonstrates Preclinical Activity in Chronic Lymphocytic Leukemia.
Int J Mol Sci
; 23(12)2022 Jun 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35743155
15.
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Br J Haematol
; 195(5): 757-763, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34581433
16.
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphoma.
Br J Haematol
; 194(4): 690-700, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34296427
17.
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Blood
; 134(21): 1811-1820, 2019 11 21.
Artigo
Inglês
| MEDLINE | ID: mdl-31558467
18.
Reproducing the molecular subclassification of peripheral T-cell lymphoma-NOS by immunohistochemistry.
Blood
; 134(24): 2159-2170, 2019 12 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31562134
19.
Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.
Blood
; 133(15): 1664-1676, 2019 04 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30782609
20.
18F-Fluorothymidine PET is an early and superior predictor of progression-free survival following chemoimmunotherapy of diffuse large B cell lymphoma: a multicenter study.
Eur J Nucl Med Mol Imaging
; 48(9): 2883-2893, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33909086